TriOptimize IX: Real-world improvement in COPD symptoms and lung function by extrafine singleinhaler triple therapy (efSITT)

被引：0
|
作者：
Trinkmann, F. [1 ]
Javan, S. Bahari [2 ]
Criee, C. [3 ]
Bogoevska, V [2 ]
Gessner, C. [4 ]
机构：
[1] Heidelberg Univ Hosp, Thoraxklin, Heidelberg, Germany
[2] Chiesi GmbH, Hamburg, Germany
[3] Evangelical Hosp Goettingen Weende, Bovenden, Germany
[4] Specialized Practice Pulm & Bronchial Med, Leipzig, Germany
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
D O I：
10.1183/13993003.congress-2022.1397
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
1397
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The Real-World Efficacy of Fixed Triple Inhalation Therapy in the Treatment of Moderate COPD Patients
    Sudi, Andras
    Santa, Balazs
    Horvath, Alpar
    Tomisa, Gabor
    Abonyi-Toth, Zsolt
    Rokszin, Gyorgy
    Eszes, Noemi
    Mueller, Veronika
    Tamasi, Lilla
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2024, 19 : 1943 - 1955
  • [22] Triple Inhaler versus Dual Bronchodilator Therapy in COPD: Real-World Effectiveness on Mortality
    Suissa, Samy
    Dell'Aniello, Sophie
    Ernst, Pierre
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2022, 19 (01) : 1 - 9
  • [23] Real-World Effectiveness of Single-Inhaler Triple Therapy for COPD: Impact of Diabetes Comorbidity
    Eilat-Tsanani, Sophia
    Ernst, Pierre
    Suissa, Samy
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2024, 21 (01)
  • [24] Real-World Outcomes on Spacer used with Extrafine Single-Inhaler Triple Therapy in Asthma Patients-TriMaximize Study
    Trinkmann, F.
    Nachtigall, D.
    Bogoevska, V
    Akyildiz, B.
    Borucki, T.
    Grickschat, V
    Gessner, C.
    PNEUMOLOGIE, 2024, 78 : S4 - S4
  • [25] TriOptimize II: The Use of Blood Eosinophil Count in the Care of Patients with COPD Prescribed Single Inhaler Therapy: A Real-World View from Germany
    Hoevelmann, R.
    Javan, Bahari S.
    Melchior, K.
    Pfeffermann, A.
    Gessner, C.
    PNEUMOLOGIE, 2020, 74 : S43 - S43
  • [26] Prescribing Pathways from Initial Medication Use to Triple Therapy in COPD: A Real-World Population Study
    Jiang, L.
    Kendzerska, T.
    Stanbrook, M. B.
    Tan, W. C.
    Stukel, T.
    Aaron, S. D.
    Gershon, A. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [27] Triple Therapy Treatment Pathways in Chronic Obstructive Pulmonary Disease (COPD): A Real-World Predictive Model
    Bogart, M.
    Oakland, T.
    Liu, Y.
    Enev, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [28] Effects Of Extrafine Single Inhaler Triple Therapy On Lung Function In COPD Patients: Results From Responder Analysis From The Trinity Study
    Scuri, M.
    Vestbo, J.
    Papi, A.
    Corradi, M.
    Montagna, I.
    Francisco, C.
    Cohuet, G.
    Vezzoli, S.
    Muraro, A.
    Petruzzelli, S.
    Singh, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [29] The Use of Inflammation Parameters in the Care of Patients with Asthma Prescribed Extrafine Single-Inhaler Triple Therapy: A Real-World View from Germany
    Gessner, C.
    Akyildiz, B.
    Nachtigall, D.
    Nudo, E.
    Boeing, S.
    Timmermann, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [30] Extrafine Beclometasone Dipropionate/Formoterol Fumarate vs Double Bronchodilation Therapy in Patients with COPD: A Historical Real-World Non-Inferiority Study
    Voorham, Jaco
    Baldi, Simonetta
    Santoro, Luigi
    Kerkhof, Marjan
    Contoli, Marco
    Fabbri, Leonardo M.
    Kerstjens, Huib A. M.
    Lopez-Campos, Jose Luis
    Roche, Nicolas
    Singh, Dave
    Vogelmeier, Claus F.
    Price, David B.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 2739 - 2750
12345